Reduction of risk diarrhoea
View Patent ↗The use of a probiotic Lactobacillus rhamnosus and a probiotic Bifidobacterium longumin the manufacture of a medicament or therapeutic nutritional composition for administration to an infant during at least the first three months of life for the long-term prophylaxis of diarrhea in infants and young children.
1. A method for reducing the risk of diarrhea in an infant comprising the steps of administering to an infant during at least the first three months of life for the long-term prophylaxis of diarrhea, a composition comprising a therapeutically effective amount of a probiotic Lactobacillus rhamnosus and a probiotic Bifidobacterium longum , wherein the composition is administered to the infant via the breast-feeding mother.
2. The method of claim 1 , wherein the probiotic Lactobacillus rhamnosus is selected from the group consisting of Lactobacillus rhamnosus ATCC 53103 and Lactobacillus rhamnosus CGMCC 1.3724.
3. The method of claim 1 , wherein the probiotic Bifidobacterium longum is Bifidobacterium longum ATCC BAA-999.
4. The method of claim 1 , wherein the composition is administered to the infant for the first 4 to 6 months of life.
5. The method of claim 1 , wherein the composition comprises a total of between 10e5 and 10e11 cfu of probiotic bacteria per daily dose.
6. The method of claim 1 , wherein the composition comprises a total of between 10e3 and 10e12 cfu of probiotic bacteria per gram of composition (dry weight).
7. The method of claim 1 , wherein the composition is a therapeutic nutritional composition.
8. The method of claim 1 , wherein the composition is a medicament.